Kolkata, June 13, 2026: Yashoda Hospitals Hyderabad highlighted its pioneering achievements in Pulmonology, Interventional Pulmonology, Thoracic Surgery, Robotic Surgery, and Lung Transplantation during a press interaction held in Kolkata, reaffirming its leadership in advanced respiratory and transplant care in India.
Addressing the media, leading specialists Dr. Manjunath Bale and Dr. J. V. S. Aswith Chowdary shared insights into the latest advancements in robotic thoracic surgery, lung cancer treatment, interventional pulmonology, and lung transplantation. The experts emphasized how cutting-edge technology, combined with multidisciplinary expertise, is transforming patient outcomes and making complex respiratory treatments safer and more effective.
Dr. Manjunath Bale highlighted that Yashoda Hospitals is among the country’s leading centres for advanced VATS, robotic thoracic surgery, and lung transplantation. He noted that the hospital performed India’s first Uniportal Robotic Thoracic Surgery and continues to lead in minimally invasive thoracic procedures. The hospital is also among the select centres offering Hyperthermic Intra-Thoracic Chemotherapy (HITHOC), advanced tuberculosis surgery, and comprehensive lung cancer management through its dedicated Lung Nodule Clinic.
Dr. J. V. S. Aswith Chowdary underscored the rising burden of respiratory diseases such as asthma, COPD, interstitial lung disease (ILD), and lung cancer in India. He stressed the importance of early diagnosis, advanced bronchoscopy, and interventional pulmonology in improving survival rates and quality of life for patients.
Among its landmark accomplishments, Yashoda Hospitals performed the first lung transplantation in the Telugu States in 2012 and later achieved another milestone with the region’s first combined Heart-Lung Transplant. The hospital also made national headlines by successfully performing India’s first double lung transplantation for paraquat poisoning, a rare and highly complex procedure.
Backed by one of India’s most advanced Heart & Lung Transplant Programs, Yashoda Hospitals reports one-year post-transplant survival rates comparable to leading global centres. The institution’s state-of-the-art infrastructure includes ECMO support, dedicated transplant ICUs, modular operating theatres, and comprehensive rehabilitation services.
The hospital further earned recognition during the COVID-19 pandemic for managing a large volume of critically ill respiratory patients, including extensive ECMO-supported treatments and emergency air ambulance transfers from across the country.
The press meet concluded with discussions on emerging trends in respiratory medicine, robotic thoracic surgery, organ transplantation, and the future of advanced pulmonary healthcare. Yashoda Hospitals reiterated its commitment to expanding access to world-class respiratory and transplant care for patients across Eastern India through innovation, clinical excellence, and patient-centric treatment.
